HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

isopropyl methylphosphonic acid

Also Known As:
IMPA
Networked: 26 relevant articles (3 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Uysal, Tancan: 2 articles (11/2012 - 07/2012)
2. Johnson, Kirstin C: 2 articles (03/2012 - 01/2012)
3. Mackin, Andrew: 2 articles (03/2012 - 01/2012)
4. Foster, J D: 1 article (05/2014)
5. Sample, S: 1 article (05/2014)
6. Muir, P: 1 article (05/2014)
7. Trepanier, L A: 1 article (05/2014)
8. Kohler, R: 1 article (05/2014)
9. Watson, K: 1 article (05/2014)
10. Chen, Sihui: 1 article (01/2014)

Related Diseases

1. Malocclusion (Crossbite)
03/01/2010 - "(1) The constructed artificial neural network in this study was effective, with 80% accuracy, in determining whether extraction or nonextraction treatment was best for malocclusion patients between 11 and 15 years old; (2) when the clinician is predicting whether an orthodontic treatment requires extraction, the indices "anterior teeth uncovered by incompetent lips" and "IMPA (L1-MP)" should be taken into consideration first."
04/01/1982 - "Treatment variations of IMPA in relation to extraction areas, and the class of malocclusion."
04/01/2007 - "Activator and high-pull headgear combination treatment in these growing patients resulted in a correction of the skeletal Class II relationship (ANB -3.4 degrees), a restriction of maxillary growth (SNA -2.0 degrees, OLp-A -2.3 mm), an advancement of the mandibular structures (SNB +2.6 degrees, FH-NPg +2.3 degrees, OLp-B +2.7 mm, OLp-Pg +2.2 mm), an increase in lower face height (ANS-Me +3.9 mm), a correction of the overjet (-5.4 mm), an improvement in overbite (-2.2 mm), uprighting of the maxillary incisors (U1-FH -5.3 degrees, OLp-U1 -2.5 mm), protrusion of the mandibular incisors (IMPA +2.0 degrees, OLp-L1 +2.7 mm), and a correction of the dental Class II malocclusion (OLp-L6 +3.5 mm). "
03/01/2004 - "These entities summarize the clinical features of a patient's condition with a quantifiable, objective list of target disorders that represent the common elements of an orthodontic diagnosis: overjet, overbite, anterior open bite, lateral open bite, crowding, occlusion, lingual posterior crossbite, buccal posterior crossbite, ANB angle, IMPA, and SN-GoGn angle. "
2. Overbite
11/01/2012 - "Statistical comparisons showed that SNA (p<0.01), ANB (p<0.01), A to N perp (p<0.05), convexity (p<0.05), IMPA (p<0.05) and overbite (p<0.05) measurements were significantly lower in MB group when compared to NB group. "
07/01/2012 - "Statistical comparisons showed that sagittal measurements including SNA (p < 0.01), ANB (p < 0.01), A to N perp (p < 0.05), convexity (p < 0.05), IMPA (p < 0.05) and overbite (p < 0.05) measurements were found to be lower in MB patients compared to NB. "
07/01/2006 - "Bolton discrepancies related to overall ratio had significant correlations with overjet (P < .05) in Class I cases, with overbite (P < .05) and U1-SN angle (P < .01) in Class II cases, and with IMPA (P < .01) in Class III cases. "
04/01/2007 - "Activator and high-pull headgear combination treatment in these growing patients resulted in a correction of the skeletal Class II relationship (ANB -3.4 degrees), a restriction of maxillary growth (SNA -2.0 degrees, OLp-A -2.3 mm), an advancement of the mandibular structures (SNB +2.6 degrees, FH-NPg +2.3 degrees, OLp-B +2.7 mm, OLp-Pg +2.2 mm), an increase in lower face height (ANS-Me +3.9 mm), a correction of the overjet (-5.4 mm), an improvement in overbite (-2.2 mm), uprighting of the maxillary incisors (U1-FH -5.3 degrees, OLp-U1 -2.5 mm), protrusion of the mandibular incisors (IMPA +2.0 degrees, OLp-L1 +2.7 mm), and a correction of the dental Class II malocclusion (OLp-L6 +3.5 mm). "
10/01/2000 - "The following measurements showed statistically significant skeletal relapse over time, for the P value.0028: Co-Go, ANS-Xi-Pm, IMPA, overbite, and overjet. "
3. Infection
4. Paratuberculosis (Johne's Disease)
5. Pain (Aches)

Related Drugs and Biologics

1. Carbon Monoxide
2. Interleukin-6 (Interleukin 6)
3. Biological Markers (Surrogate Marker)
4. Sarin
5. C-Reactive Protein
6. Antigens
7. Alkaline Phosphatase
8. leflunomide (Arava)
9. HLA-Cw3
10. tranilast (N 5')